In most FXS patients, FMR1 is hypermethylated and transcriptionally silenced resulting in decreased FMR1 mRNA and FMRP protein levels, impacting neurogenesis (Sunamura et al., 2018). Here, FMR1 is linked to fragile X syndrome.